Alkermes Management

Management criteria checks 3/4

Alkermes' CEO is Richard Pops, appointed in Sep 2011, has a tenure of 12.58 years. total yearly compensation is $9.44M, comprised of 12.5% salary and 87.5% bonuses, including company stock and options. directly owns 0.7% of the company’s shares, worth $28.14M. The average tenure of the management team and the board of directors is 4.9 years and 3.3 years respectively.

Key information

Richard Pops

Chief executive officer

US$9.4m

Total compensation

CEO salary percentage12.5%
CEO tenure12.6yrs
CEO ownership0.7%
Management average tenure4.9yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data

Apr 09

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Apr 08
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet

Jan 26

Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Nov 01
Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Nov 01
Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

Jul 15
Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Jun 07
There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Apr 10
Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Mar 20
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes upgraded to neutral at BofA on improved risk/reward outlook

Oct 14

Alkermes holder Sarissa Capital says it may look to increase its stake

Oct 07

Alkermes: Nothing Stands Out As Interesting

Sep 26

Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Aug 29
Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Alkermes initiated at neutral at Piper Sandler as company in transition

Aug 16

Alkermes Q2 2022 Earnings Preview

Jul 26

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Jun 27
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

May 16
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Alkermes: Turning The Tides Towards Profitability

Apr 16

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Feb 07
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Alkermes plc's (NASDAQ:ALKS) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 12
Alkermes plc's (NASDAQ:ALKS) Intrinsic Value Is Potentially 100% Above Its Share Price

CEO Compensation Analysis

How has Richard Pops's remuneration changed compared to Alkermes's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$9mUS$1m

US$519m

Sep 30 2023n/an/a

US$215m

Jun 30 2023n/an/a

US$103m

Mar 31 2023n/an/a

-US$164m

Dec 31 2022US$10mUS$1m

-US$33m

Sep 30 2022n/an/a

-US$129m

Jun 30 2022n/an/a

-US$94m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$9mUS$1m

US$76m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$95m

Dec 31 2020US$8mUS$1m

-US$111m

Sep 30 2020n/an/a

-US$74m

Jun 30 2020n/an/a

-US$126m

Mar 31 2020n/an/a

-US$139m

Dec 31 2019US$15mUS$1m

-US$197m

Sep 30 2019n/an/a

-US$201m

Jun 30 2019n/an/a

-US$183m

Mar 31 2019n/an/a

-US$173m

Dec 31 2018US$17mUS$1m

-US$139m

Sep 30 2018n/an/a

-US$139m

Jun 30 2018n/an/a

-US$141m

Mar 31 2018n/an/a

-US$152m

Dec 31 2017US$9mUS$964k

-US$158m

Compensation vs Market: Richard's total compensation ($USD9.44M) is above average for companies of similar size in the US market ($USD6.66M).

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.


CEO

Richard Pops (61 yo)

12.6yrs

Tenure

US$9,442,066

Compensation

Mr. Richard F. Pops has been the Chief Executive Officer and Director of Alkermes PLC since September 2011 and its Chairman since September 16, 2011. Mr. Pops was the Founder of Genomics Collaborative, Inc...


Leadership Team

NamePositionTenureCompensationOwnership
Richard Pops
Chairman & CEO12.6yrsUS$9.44m0.70%
$ 28.1m
Blair Jackson
Interim Principal Financial Officer3.3yrsUS$4.56m0.093%
$ 3.8m
David Gaffin
Executive VP7.9yrsUS$4.14m0.097%
$ 3.9m
Iain Brown
Senior VP & CFO (Leave of Absence)less than a yearUS$3.21m0.069%
$ 2.8m
Craig Hopkinson
Executive VP of Research & Development and Chief Medical Officer6.9yrsUS$4.23m0.065%
$ 2.6m
Floyd Bloom
Founderno dataUS$324.96kno data
Samuel Parisi
Interim Principal Accounting Officer & VP of Financeless than a yearno data0.0046%
$ 184.0k
Thomas Harvey
Chief Information Officer & Senior VP of IT6yrsno datano data
Sandra Coombs
Senior Vice President of Corporate Affairs & Investor Relationsno datano datano data
Stephen Schiavo
Senior Vice President of Human Resources3.8yrsno datano data
Peter Norman
Senior Vice President of Policy & Government Relationsno datano datano data
Declan O'Connor
Senior Vice President of Operations and Environmentno datano datano data

4.9yrs

Average Tenure

54yo

Average Age

Experienced Management: ALKS's management team is considered experienced (4.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Richard Pops
Chairman & CEO12.6yrsUS$9.44m0.70%
$ 28.1m
Brian McKeon
Independent Director3.3yrsUS$482.04k0.020%
$ 790.5k
Nancy Snyderman
Independent Director7.9yrsUS$482.04k0.012%
$ 495.5k
Nancy Lurker
Independent Directorless than a yearno datano data
Shane Cooke
Independent Director6.1yrsUS$449.04k0.057%
$ 2.3m
David Daglio
Independent Director3.3yrsUS$474.04k0.061%
$ 2.5m
Cato Laurencin
Independent Director2.4yrsUS$459.04k0.0090%
$ 361.9k
Frank Wilson
Lead Independent Director4.6yrsUS$486.65k0.012%
$ 485.4k
Christopher Wright
Independent Director1.9yrsUS$463.12k0.0043%
$ 173.5k
Richard B. Gaynor
Independent Director4.6yrsUS$464.69k0.012%
$ 485.4k
Emily Alva
Independent Director2.9yrsUS$469.04k0.012%
$ 470.5k

3.3yrs

Average Tenure

61yo

Average Age

Experienced Board: ALKS's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.